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Abstract
Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytotoxic, CD8+ T-
lymphocytes. Here we show that these cytotoxic T-lymphocytes perturb retrograde axonal transport. Using fluorogold
stereotactically injected into the colliculus superior, we found that PLP overexpression in oligodendrocytes led to
significantly reduced retrograde axonal transport in retina ganglion cell axons. We also observed an accumulation of
mitochondria in the juxtaparanodal axonal swellings, indicative for a disturbed axonal transport. PLP overexpression in the
absence of T-lymphocytes rescued retrograde axonal transport defects and abolished axonal swellings. Bone marrow
transfer from wildtype mice, but not from perforin- or granzyme B-deficient mutants, into lymphocyte-deficient PLP mutant
mice led again to impaired axonal transport and the formation of axonal swellings, which are predominantly located at the
juxtaparanodal region. This demonstrates that the adaptive immune system, including cytotoxic T-lymphocytes which
release perforin and granzyme B, are necessary to perturb axonal integrity in the PLP-transgenic disease model. Based on
our observations, so far not attended molecular and cellular players belonging to the immune system should be considered
to understand pathogenesis in inherited myelin disorders with progressive axonal damage.
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Introduction
An important consequence of many myelin disorders is the
degeneration of axons. Although it is well established that myelin
and glial perturbation often leads to axon damage, the mechan-
isms involved are not yet entirely understood. Early trans-
plantation studies performed in the peripheral nervous system
using nerve segments from trembler mice unequivocally demon-
strated that glial cells can locally influence axonal properties
including axonal transport [1]. Other studies in the central
nervous system on mice deficient in PLP or 29, 39 -cyclic
nucleotide 39-phosphodiesterase also showed that mutant myeli-
nating cells impair retrograde axonal transport [2] or cause
features indicative of defective axonal transport [3], revealing
a tight link beween the molecular integrity of myelinating glial cells
and maintenance of axons [4,5].
Importantly, most studies focussing on glia-related axon
transport impairment were considering a two-cell scenario,
comprising an abnormal myelinating glial cell and the axon
directly affected by glial abnormalities by mainly unknown
mechanisms. Using mice overexpressing PLP and serving as
a model for X-linked spastic paraplegia type-2 [6,7] our
laboratory recently identified cytotoxic T-lymphocytes as
mediators of primarily gliogenic neural damage [8,9,10,11].
However, it was not investigated whether the low-grade
inflammation also affected axonal transport.
In the present study, we specifically investigated the impact of
neuroinflammation on retrograde axonal transport, a reliable
parameter for examining axonal integrity [2,12,13,14]. Of note,
impaired axonal transport is also a pathological feature of various
adult onset neurodegenerative diseases like Alzheimer’s disease,
Huntington’s disease, motor neuron diseases or Parkinson’s disease
[15,16,17,18] and, interestingly, these disorders have often been
found as being associated with inflammation of pathogenic
relevance [19,20].
We found that in PLP overexpressing mutants, the presence of
functional cytotoxic T-cells is mandatory for glia-induced impair-
ment of retrograde axonal transport and that this pathogenic effect
is mediated by perforin and granzyme B. This finding substantially
extends our knowledge about the pathomechanisms underlying
primarily gliogenic axon perturbation.
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Results
Compounds of the Adaptive Immune System Reduce the
Efficacy of Retrograde Transport in PLP-tg Mice
To investigate whether axonal transport is impaired in PLP
overexpressing (PLP-tg) mice and, eventually, whether the
immune system is involved in this potential perturbation, we first
analyzed the axonal transport by retrograde labeling of retina
ganglion cells (RGCs) after injection of fluorogold into the
colliculus superior. 6 days after tracer injection, we counted 22%
less labeled RGCs in the PLP-tg mutants compared to wt mice
(p,0.05) (Figure 1A, B). Interestingly, when the time period for
retrograde axonal transport was extended from 6 to 14 days, the
reduction of labeled RGCs in PLP-tg mutants dropped to 11%
and was no longer statistically significant (Figure 1C). This
amelioration by an extended time period indicates that in the
mutants, the efficacy of retrograde axonal transport was sub-
stantially reduced, and that axonal transection cannot be the
major reason for the reduced number of labeled RGCs.
Additionally, we counted the number of RGCs in flat mount
preparations using histochemical (Nissl) staining. In both PLP-wt
mice and PLP-tg mice, a comparable number of RGCs was
detectable (Figure 1D), indicating that the oligodendrogliopathy
did not lead to considerable neuronal cell death. Thus, in the PLP-
tg mice, the efficacy of retrograde axonal transport was sub-
stantially reduced, but axonal transection was minor.
Next, we examined the efficacy of retrograde axonal transport
in PLP-tg RAG-12/2 mice that lack functional T-and B-
lymphocytes (but not NK cells) due to a null mutation in the
recombination activating gene (RAG)-1 [8]. In the tracing
experiments with a transport time of 6 days, we found more
retrogradely labeled RGCs in the PLP-tg RAG-12/2 mice than
in immune-competent PLP-tg mutants (PLP-tg RAG-1 wt), with
values similar to those obtained by PLP-wt mice (Figure 1A, B).
Then we investigated whether perforin and granzyme B, the
typical cytotoxic mediators of CD8-positive T-lymphocytes, also
disturb retrograde axonal transport. We created chimeric mice by
bone marrow transplantation from either perforin- or granzyme B-
deficient mutants into PLP-tg RAG-1-deficient mice. We found
that in PLP-tg mutants with T-lymphocytes lacking perforin or
granzyme B, the number of retrogradely labeled RGCs was at the
level of wt mice (Figure 1E), showing that perforin and granzyme
B are important mediators of perturbation of retrograde axonal
transport in the myelin mutants. Of note, the T-lymphocytes
lacking perforin or granzyme B invaded the mutant CNS to
a similar degree as in genuine PLP-tg mice (not shown). Control
transplantation experiments with wt bone marrow led to a re-
duction of retrogradely labeled RGCs comparable to PLP-tg
RAG-1 wt mice (Figure 1E).
Juxtaparanodes are Perturbed in Immunocompetent
PLP-tg Mice
Using Bielschowsky’s silver impregnation, axon enlargements/
swellings were identified as correlates of axonal perturbation in
PLP-tg mice (Figure 2A). Furthermore, RAG-1-, perforin- and
granzyme B-deficiency caused a significant reduction of such
abnormalities compared to immune-competent PLP-tg mice
(Figure 2A).
We now further characterized the axonal abnormalities within
optic nerves of 3 PLP-tg mice by electron microscopy to determine
their relative positions along the myelin sheath. The majority of
axonal enlargements was located at the juxtaparanodal region
distal to the node of Ranvier with regard of the retina ganglion cell
bodies (Figure 2B, C). Typically, there was a substantial accumu-
lation of mitochondria. Sometimes, the mitochondria appeared
though as if they would ‘‘plug’’ the axon constriction at the
transition between the paranode and the juxtaparanode
(Figure 2C). The mitochondria, furthermore, often showed
morphological alterations, ranging from almost normal appear-
ance to contorted structures reminiscent of mitochondria fused to
lysosomes (Figure 2C, D).
Dynein Protein Level is Increased in PLP-tg Mice
Dynein is the major motorprotein mediating the retrograde
axonal transport. Because of the impaired retrograde axonal
transport in PLP-tg mice, we therefore analyzed the protein levels
of dynein in triton-soluble extracts of PLP-tg mouse optic nerves.
Western blot analysis showed an increase of dynein protein level in
PLP-tg mouse optic nerve compared to extracts from optic nerves
of PLP-wt mice. RAG-1 deficiency led to dynein levels comparable
to those seen in PLP-wt mice in PLP-tg mice (Figure 2E, F).
CD8+ T-lymphocytes Contact Juxtaparanodal Regions
where they Acquire an Elongated Shape
To further investigate whether there is a spatial relationship
between CD8+ T-lymphocytes and juxtaparanodal regions, we
performed double immunofluorescence using antibodies against
CD8 and Caspr2. Indeed, we often observed a close association
between CD8+ T-lymphocytes and Caspr2+ profiles in all
genotypes investigated. In PLP-tg mice, we found approximately
4-fold more CD8+ T-lymphocyte-to-juxtaparanode contacts in
relation to the number of juxtaparanodes than in PLP-wt mice
(0.25% vs 0.06%, p,0.05) (Figure 3A). Additionally, confocal
microscopy revealed that in PLP-tg mice, 41.3% 611.6% of all
CD8+ T-lymphocytes in the optic nerve sections are attached to
the juxtaparanodes. Of note, CD8+ T-lymphocytes remote to
Caspr2+ profiles were mostly rounded, whereas CD8+ T-
lymphocytes at juxtaparanodal regions preferentially displayed
an elongated shape (Figure 3B, C). As a quantitative measure, this
was reflected by a higher form factor (representing a more
rounded shape, see Materials and Methods) in the former group
and by a lower form factor of T-lymphocytes associated with
Caspr2+ profiles (Figure 3B–D). Interestingly, the elongated,
attaching T-lymphocytes often displayed protrusions from one end
of the cell body that contacted the juxtaparanode (Figure 3C).
Discussion
In the present study, we could unequivocally demonstrate that
lymphocytes mediate axonal perturbation in PLP overexpressing
mutant mice. As typical for cytotoxic T-lymphocytes this
impairment was most likely mediated by perforin and granzyme
B. These findings do not only identify some elements of the basic
mechanisms of axon perturbation in PLP mutants, but also
demonstrate that at least in the present mutant, glial perturbation
alone is not sufficient for robust axon impairment, but needs the
involvement of a ‘‘third‘‘ cellular component, the immune cell.
This is clearly reflected by normal, wild-type-like efficacy of axonal
transport in the presence of the glial mutation, but in the absence
of lymphocytes or when lymphocytic effector cells are molecularly
impaired.
Our study strongly suggests that reduced retrograde labeling in
the optic system is mediated by impaired retrograde axonal
transport per se, rather then by complete axonal transection which
would lead to a reduced number of labeled retina ganglion cell
bodies as well. Of note, in a related mutant, simultaneous
injections of axonal tracers into the superior colliculus (retrograde
transport) and the retina (anterograde transport) identified double-
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labeled axonal bulbs reflecting axonal continuity in the presence of
axonal abnormalities and impaired retrograde axonal transport
[21]. For the present study, there are at least two arguments
strongly favouring the continuity of the vast majority of retina
ganglion cell axons. First, extention of the time period for
retrograde axonal transport leads to a substantial increase of
retrogradely labeled neuronal cell bodies in the PLP mutants. This
shows that, in the PLP mutants, axons transport the tracer with
a reduced efficacy and need extended time periods to generate
detectable labeling levels in some cell bodies. Reciprocally, if
reduced numbers of labeled retinal ganglion cell bodies would
have been caused predominantly by axonal transection, it is
unlikely that extended time periods for retrograde axonal transport
would have elevated the number of labeled cell bodies in the
retina. Second, as a more indirect argument, retinal ganglion
neurons are highly susceptible to cell death when axons are
completely transected, either mechanically [22,23] or by neuroin-
flammation [12]. In our study, we could neither find a significant
reduction of retina ganglion cells nor pyknotic cell nuclei by
histological stainings, suggesting that axonal continuity is mostly
preserved in the PLP mutants. Thus, in the PLP mutants, axons
appear morphologically altered [8], but not entirely transected.
This has important implications for therapies aimed at rescuing
injured axons, because it demonstrates the potential reversibility of
such axonal changes [24].
To further elucidate the nature of disturbed retrograde axonal
transport in PLP overexpressing mice we investigated the motor
protein for retrograde transport in optic nerve lysates. A significant
increase of dynein protein level was detected in PLP-tg mouse
optic nerves compared to PLP-wt mice. Similar results with
elevated dynein levels have been observed in PLP-null mice that
also show disturbed axonal transport [2]. It has been suggested
that raised dynein protein levels might reflect an accumulation of
dynein-linked retrogradely moving organelles [2]. This is in line
with our finding that juxtaparanodal axonal swellings with
morphologically-altered mitochondria were located predominant-
ly on the distal side of the node of Ranvier (in regard to the retina).
Accumulation of mitochondria or other cell organelles in axonal
abnormalities are often a correlate for disturbed axonal transport
[2,25,26,27] thus suggesting a link between the impaired
retrograde axonal transport and the formation of the juxtapar-
anodal swellings and increase in dynein protein levels. These
features were nearly restored in the absence of RAG-1 in PLP-tg
mice suggesting a central role of adaptive immune cells in
axonopathic changes in the respective mutants.
Since in our study, juxtaparanodes appeared to be most
susceptible for changes mediated by the cytotoxic T-lymphocytes,
we investigated the possible association of these structures. Indeed,
T-lymphocytes in direct vicinity to juxtaparanodes were detectable
and, most interestingly, preferentially displayed a spindle-like
shape at this location. We do presently not know the significance of
this constant observation, but it is worthwhile to speculate that
increased adhesion to a possible target structure might lead to the
maximal cell contact extension between lymphocytes and the
juxtaparanode resulting in the elongated shape of the lymphocytes.
Interestingly, this phenomenon has been observed also in perforin-
and granzyme B-deficient myelin mutants suggesting that this cell-
cell interaction is independent of the cytotoxic features of the
lymphocytes. Whether typical axo-glial molecules, which can even
serve as antigens in multiple sclerosis [28], are functionally
involved in this interaction, remains to be resolved.
Our basic finding that cytotoxic lymphocytes with their
respective cytotoxic agents are essential for impaired retrograde
axonal transport is reminiscent of the pathomechanisms described
in Theiler’s virus-related model of demyelination [29,30,31,32].
However, in contrast to the Theiler’s virus model, in PLP
transgenic mice MHC class I immunoreactivity is only detectable
on the mutant oligodendrocytes [8]. This might have substantial
consequences for the respective pathomechanisms. For the
Theiler’s virus model, it is assumed that the virus-mediated
demyelination exposing the MHC class I-positive axolemma is an
important prerequisite for the formation of an immunological
synapse between lymphocytes and MHC class I-positive axons
and, thus eventually, for the immune attack by the cytotoxic T-
cells [29,30,31,32]. In the PLP mutant, in which MHC I-restricted
T-cell receptors play a crucial role for neural damage [10],
cytotoxic T-cells might only be able to attack the MHC class I-
positive oligodendrocytes, since the molecule is not detectable on
axons [8]. Paradoxically, in the PLP mutants, myelin often
remains intact over wide stretches of the internodes whereas the
axons show shrinkage or swelling causing periaxonal vacuoles [8]
and axonal enlargements [10], respectively. This scenario
resembles pathological features seen in MOG-EAE, where the
immunological attack against the target cell, the oligodendrocyte,
is transmitted to the axon without major local damage to myelin
[24,33]. How the glial-related attack is transmitted to the axonal
partner and whether the spindle-shaped lymphocytes (see above)
directly attaching to the juxtaparanodes are the cytotoxic
mediators is presently not clear.
The primary defect of PLP transgenic mice clearly resides in
mutant oligodendrocytes. Axonal pathology, on the other hand, is
strongly reduced on the RAG-12/2 background, but unlike the
absence of lymphocytes not completely abolished [8]. Thus,
secondary axonal swellings and periaxonal vacuoles in a primary
glial disease can – at a low level - principally exist also independent
of invading cytotoxic T-lymphocytes, which therefore emerge as
Figure 1. Retrograde transport is impaired in PLP-tg mutants, but reconstituted in the absence of the adaptive immune system and
its cytotoxic molecules perforin and granzyme B. A) Retina flat mounts (middle region) from 10 months-old wild type (PLP-wt), PLP-tg (PLP-tg
RAG-1 wt) and immune-deficient PLP-tg (PLP-tg RAG-12/2) mice after 6 days of retrograde axonal transport of fluorogold. Different cell sizes and
fluorogold intensity of labeled RGCs are visible. Note that in immune-competent PLP-tg mice, less retrogradely labeled RGCs are detectable than in
PLP-wt, where nearly all RGCs are retrogradely labeled. In immune-deficient PLP-tg mice, the number of labeled RGCs is comparable to that of PLP-wt
mice. B) Quantification of retrogradely labeled RGCs of PLP-wt (n = 5), PLP-tg RAG-1 wt (n = 5) and PLP-tg RAG-12/2 (n = 5) mice. In comparison to
PLP-wt mice, less RGCs were labeled in PLP-tg mice. In PLP-tg RAG-12/2 mice, a similar number of RGCs was labeled as in PLP-wt mice. C) Relative
reduction of retrogradely-labeled RGCs of PLP-tg (n = 5) in comparison to PLP-wt (n = 4) mice, dependent on the time period for retrograde axonal
transport. The extention of the time period for retrograde transport of fluorogold from 6 to 14 days leads to a drop of reduced retrograde labeling of
RGCs, indicating that retrograde axonal transport, rather than the continuity of the axons, is impaired. *significant reduction of labeled RGCs in
comparison to wt mice (p,0.05). D) Quantification of Nissl-stained RGCs of PLP-wt (n = 5), PLP-tg RAG-1 wt (n = 5) and PLP-tg RAG-12/2 (n = 5) mice.
Note that the number of Nissl-stained RGCs is not reduced in the PLP-tg mutants, as opposed to retrogradely labeled RGCs (Figure 1B). E)
Quantification of retrogradely labeled RGCs (6 days period for retrograde axonal transport) of PLP-wt (n = 5), PLP-tg RAG-1 wt (n = 5) and PLP-tg RAG-
12/2mice reconstituted with bone marrow (BM) from either wild type mice (PLP-tg RAG-12/2 wt BM, n = 5), perforin- (PLP-tg RAG-12/2 Perforin -,
n = 4) or granzyme-B-deficient mice (PLP-tg RAG-12/2 GzmB -, n = 4). Note that lack of either cytotoxic perforin or granzyme B leads to
a reconstitution of retrograde axonal transport to PLP-wt level.
doi:10.1371/journal.pone.0042554.g001
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Figure 2. The occurrence of axonal swellings depend on lymphocytes, cytotoxic perforin or granzyme B and are located at
juxtaparanodal aspects. A) Number of axonal swellings (Bielschowsky’s silver impregnation, optic nerve) in PLP-wt (n = 3), PLP-tg RAG-1 wt (n = 4),
PLP-tg RAG-12/2 (n = 5) mice and in PLP-tg mice devoid of cytotoxic perforin (n = 3) or granzyme B (n = 3). RAG-1 deficiency and lack of cytotoxic
perforin or granzyme B in PLP-tg mice leads to a significant reduction of axonal swellings (p,0.05, one-sided student’s t-test). B) Quantification of
axonal swellings in 3 PLP-tg RAG-1 wt mice by electron microscopy displays that the majority of these abnormalities are located at the
juxtaparanodal region while only few abnormally organized structures are located at other domains of the myelinated fiber. Note that the paranode
is not abnormally organized. C, D) Electron microscopy of PLP-tg mouse optic nerves identifies abnormal juxtaparanodal and internodal profiles,
containing mitochondria (asterisks), often with an appearance reminiscent of degeneration. An axonal swelling in an undefined region is marked by
an ‘‘U’’. N: Node of Ranvier; P: Paranode; J: Juxtaparanode; I: Internode. E, F) Western blot analysis of optic nerves of PLP-wt, PLP-tg RAG-1 wt and PLP-
tg RAG-12/2 mice. E) In this example with one individual for each genotype, dynein levels are elevated in PLP-tg RAG-1 wt mice compared to PLP-
wt. RAG-1 deficiency leads to dynein levels in PLP-tg mice comparable to those found in PLP-wt mice. ERK1/2 was used as loading control. F)
Quantitative Western blot analysis using densitometry and 3–5 individuals per genotype confirm the elevated dynein levels in PLP-tg RAG-1 wt mice
compared to PLP-wt. RAG-1 deficiency leads to dynein levels in PLP-tg mice comparable to those found in PLP-wt mice.
doi:10.1371/journal.pone.0042554.g002
Figure 3. CD8+ T-lymphocytes contact juxtaparanodes where they acquire a spindle-shaped form. A) Relative number of CD8/Caspr2
contacts in PLP-wt (n = 6) and PLP-tg (n = 5) mouse optic nerves. In PLP-tg mice, significantly more CD8+ T-lymphocyte-to-juxtaparanode contacts are
visible than in the PLP-wt mice. B, C) Double immunofluorescence in mouse optic nerve for CD8+ T-lymphocytes (red) and Caspr2+ juxtaparanodal
regions (green). Cell nuclei are stained blue with DAPI. T-lymphocytes devoid of cell contact to Caspr2+ structures are preferentially rounded (B) while
T-lymphocytes attached to Caspr2+ structures are spindle shaped (C). D) Dot-plot showing form factor values of individual T-lymphocytes in PLP-wt,
PLP-tg and PLP-tg mice without perforin or granzyme B. At least 16 Caspr2-associated and not-associated T-lymphocytes were investigated in each
genotype (n = 2–3). Independent of the genotype, CD8+ T-lymphocytes display a low form factor representing a spindle-like shape when associated
with the juxtaparanodal region.
doi:10.1371/journal.pone.0042554.g003
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substantial ‘amplifiers’ of diseases. The cytotoxic attack by perforin
and granzyme B might alter the subcellular organisation of
oligodendrocytes causing impairment of normal diffusion and
transport processes within cytosolic channels of myelin, hypoth-
esized to play an important role in the oligodendroglial support of
axon function [4].
Alternatively, it is possible that a ‘‘spillover’’ of perforin and
granzyme(s) from invading T-cells is a collateral damage and
bystander effect that directly perturbs axon functions, as hypoth-
esized for experimental ex vivo models [34,35,36]. In this context, it
is striking that released granzyme B can damage neurons via
interaction with the neuronal mannose-6-phosphate-receptor
[37,38] which is not only located on neuronal somata and
dendrites, but also on axons [39]. In this model, the antigen-
specific cytotoxic attack to glial cells would release perforin/
granzyme B to diffuse along the myelinated fiber, eventually
binding to axonal mannose-6-phosphate receptor at the nodes of
Ranvier. This could lead to endocytosis of the granzyme B-
mannose-6-phosphate receptor-complex and release of granzyme
B into the axoplasm by a perforin-dependent process [38]. Once
granzyme B has been transfered into the cytoplasm, it could
promote reorganization of microtubules [40] or mitochondrial
damage [38] leading to impaired retrograde axonal transport.
Why, however, axonal changes are predominantly seen at
juxtaparanodes rather than at the node proper, can presently
not be explained by this model.
Irrespective of the exact pathomechanism, blocking inflamma-
tion in this model might be beneficial for the preservation of axon
transport and for the maintenance of the integrity of critical axonal
compartments, such as the juxtaparanode with its pivotal
physiological functions [41]. Of note, many neurological disorders
are associated with impaired retrograde axonal transport and
impaired axonal transport itself may also have a pathogenic
impact so that improvement of axonal transport might be
a therapeutic target to ameliorate disease [15,16,17,18,42,43].
Based on our findings, one way to improve axonal transport might
be to attenuate inflammation. Our study has therefore clear
implications also for the development of treatment strategies in the
group of inherited myelin disorders and possibly other neurode-
generative disorders that have an inflammatory component and
are marked by progressive impairment of axon function.
Materials and Methods
Ethics
Animal experiments were approved by the Regierung von
Unterfranken Wuerzburg.
Animals
10 months old heterozygous PLP overexpressing mice (PLP-tg;
PLP-tg RAG-1 wt) of the line 66 and PLP-tg RAG-12/2mutants
were examined. Perforin-deficient mice were kindly provided by
T. Hu¨nig (Wuerzburg). Granzyme B2/2 mice were obtained
from the Jackson Laboratory (Bar Harbor, ME). All investigated
mice were on a C57BL/6 background and were kept in our
animal facility under barrier conditions.
Bone marrow transplantation from wt, perforin- or granzyme B-
deficient donor mice into 8 weeks old PLP-tg RAG-12/2
mutants (hosts) and control of successful transplantation were
performed as described before [10]. Hosts were sacrificed after 8
months of survival.
Retrograde Labeling of Retina Ganglion Cells (RGCs)
Mice were anesthetized (intraperitoneally, Ketamin/Rompun)
and placed into a stereotactic frame. RGCs were retrogradely
labeled with 1.5 ml fluorogold (4% in 0.9% saline; Fluorochrome
Inc., Englewood, Colorado). Injections were given into both
colliculi superiores using stereotactic coordinates (bregma 3.6 mm
caudally, 0.6 mm laterally, and 1.75 mm ventrally). After 6 or 14
days, mice were perfused with 0.9% saline and retinae were
prepared as whole mounts (four retinal leafs) and immersion-fixed
in 4% PFA/PBS (409). For quantification of RGCs, 12 digital
images were acquired per retina (inner, middle, outer region of the
flattened retina), corresponding to locations at 1/6, 3/6 and 5/6 of
the retinal radius. All retrogradely labeled RGCs were quantified
independent of size.
CD8/Caspr2 Double-Immunohistochemistry
Freshly dissected mouse optic nerves were snap frozen in liquid
nitrogen-cooled isopentane. 10 mm thick longitudinal kryosections
were cut and immersion fixed in 2% PFA/PBS for 10 minutes at
room temperature (RT). After washing in PBS, sections were
incubated in 4% FCS/4% NGS in 0.3% Triton-X-100/PBS for
1 h at RT. Afterwards primary antibodies rat-anti-mouse-CD8
(Chemicon, Temecula, CA) and rabbit-anti-mouse-Caspr2 as
a marker for juxtaparanodes (AB5886; Millipore, Billerica, USA)
diluted in blocking solution were applied for two hours at RT,
followed by incubation with fluorescence-labeled secondary
antibodies (goat-anti-rat-Cy3, Dianova, Hamburg, Germany;
goat-anti-rabbit-Alexa Flour 488, A11008, Invitrogen, Karlsruhe,
Germany). In order to mark cellular nuclei the sections were
incubated with DAPI (Sigma-Aldrich, Munich, Germany;
1:500000) and then embedded in Aqua-Poly/Mount. DAPI
positive CD8+ T-lymphocytes and Caspr2+ profiles were counted
per mm2 in myelinated optic nerve with the confocal microscope
FluoView FV1000 (Olympus, Hamburg, Germany). Every CD8+
T-cell was completely scanned with 1 mm stacks. For the analysis
of association rate, the percentage of CD8+ T-lymphocytes
attatched to juxtaparanodal regions was quantified in relation to
the number of Caspr2+ profiles. Of each cell the stack with the
largest surface area was measured with ImageJ 1.45 (National
Institutes of Health, Bethesda, MD) for area and perimeter.
According to the formula for the form factor ( = 4 p6 cell area/
perimeter2; ref. [44]) values were obtained and compared between
different genotypes. All sections were analysed by the investigator
not being aware of the genotype.
Bielschowsky’s Silver Impregnation
10 mm optic nerve sections were incubated in 20% lead nitrate
for 30 minutes at room temperature, followed by incubation in 4%
formaldehyde (10 sec). Sections were then impregnated in lead
nitrate/ammonium hydroxide solution for 30 seconds. After
washing in distilled water, sections were incubated in 5%
sodiumthiosulfatesolution.
Electron Microscopy
Optic nerves of transcardially perfused mice (4% PFA/2% GA)
were osmificated and embedded in Spurr’s medium. 70 nm
ultrathin sections were counterstained with lead citrate and
examined using Leo 906E electron microscope (Zeiss, Oberko-
chen, Germany), equipped with a ProScan CCD camera
(Lagerlechfeld, Germany).
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Western Blot Analysis
Optic nerves were quickly dissected, snap frozen in liquid
nitrogen and sonicated (Sonoplus HD60, Bandelin electronic,
Berlin, Germany) in 100 ml RIPA lysis buffer (25 mM Tris-HCl,
pH 8, 10 mM Hepes, 150 mM NaCl, 145 mM KCl, 5 mM
MgCl2, 2 mM EDTA, 0.1% SDS, 1% NP-40, 10% Glycerol with
protease inhibitors) per 10 mg tissue. In addition, triton soluble
(membrane protein enriched) and triton insoluble fractions of optic
nerve lysates were prepared according to previously published
protocols [2]. Protein concentration was determined by Lowry
assay (Sigma-Aldrich) and equal amounts of proteins were resolved
by SDS-PAGE, transferred to nitrocellulose membranes and
visualized using Ponceau S (Roth, Karlsruhe, Germany). Mem-
branes were blocked with skim milk and probed with anti-dynein
antibody solution (intermediate chain) overnight at 4uC (Serotec,
Oxford, UK). Incubation with HRP-conjugated secondary anti-
bodies was performed for 1 h at room temperature and detection
of the immune reaction was achieved by use of ECL reagent and
ECL hyperfilm (GE Healthcare Bio-Sciences AB, Uppsala,
Sweden). The resulting signals for motor proteins were normalized
to the amount of the corresponding signal of the loading control
following densitometric quantification using ImageJ software
(National Institutes of Health, Bethesda, MD).
Statistical Analysis
Statistical analysis was performed by using the unpaired two-
tailed student’s t-test for comparison of quantified profiles. For
analysis of axonal swellings a one-tailed student’s t-test was used.
Relative reduction of retrogradely labeled RGCs was determined
by calculating the percentage of RGCs in PLP-tg RAG-1 wt
mouse retinae in relation to the number of RGCs of corresponding
PLP-wt mice.
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